No plan to ban ranitidine: MoS

Tribune News Service

New Delhi, Updated At : 04:00 AM Dec 21, 2024 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

There is no proposal to ban the manufacturing, distribution or sale of ranitidine, a medication used to reduce stomach acid, clarified Minister of State for Health Anupriya Patel.

She was responding to concerns about the presence of NDMA, a potentially harmful impurity in the medicine, in Rajya Sabha. She said the Central Drugs Standard Control Organisation (CDSCO) is testing samples for impurity and state drug controllers have been told to instruct manufacturers of ranitidine API and formulations to verify and test their products.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles